Drugs / Calcium lactate
Calcium lactate
also known as
Calcium Supplement · Calcium (as lactate) · Calcium lactate anhydrous · Calphosan · E-327 · INS NO.327 · INS-327 · Lactic acid, calcium salt (2:1)
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04239872 | Mar 2020 → Apr 2021 | — | University of Michigan | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00000415 | Apr 1998 → Feb 2003 | — | South Dakota State University | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06464718 | Jun → Dec 2022 | — | Frontier Medical and Dental College, Abbotabad | Completed | No outcome recorded |
| — | NCT06160479 | May 2022 → Sep 2023 | calcium metabolic disease | Siriraj Hospital | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01624064 Comparator | Aug → Oct 2012 | chronic kidney disease | Ministry of Health, Sri Lanka | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00729183 Background | Oct 2008 → Mar 2010 | osteoporosis | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00670501 Background | Aug 1996 → Apr 1999 | postmenopausal osteoporosis | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01753856 Background | Jan 2013 → Jun 2014 | osteoporosis | Eli Lilly and Company | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07364279 Background | Nov 2024 → Nov 2025 | osteoporosis | Cairo University | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium lactate | “Calcium lactate, at a concentration of 150 milimolar, will be used to rinse the mouth for 1 minute and expectorated; immediately after, a sodium fluoride rinse, at a...” NCT04239872 ↗1“Electrolyte mix containing 500 mg calcium as calcium lactate” NCT06464718 ↗ |
| Known as | Calcium (as lactate) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106111 ↗ |
| Known as | Calcium lactate anhydrous | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106111 ↗ |
| Known as | Calcium Supplement | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00670501 ↗ |
| Known as | Calphosan | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106111 ↗ |
| Known as | E-327 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106111 ↗ |
| Known as | INS NO.327 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106111 ↗ |
| Known as | INS-327 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106111 ↗ |
| Known as | Lactic acid, calcium salt (2:1) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106111 ↗ |
| Modality | Small molecule | — CHEMBL2106111 ↗ |
| Route | Oral | “Approximately 1000 mg/day of elemental calcium will be supplied as open-label oral supplement” NCT00670501 ↗ |